This is the
official Google+ page for Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.
Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics.
Teva currently employs approximately 47,000 people around the world and reached $16.1 billion in net sales in 2010.
Note to Users: This page is intended to provide news and updates about our company, and Teva reserves the right to delete any comments that it considers to be inappropriate, abusive or spam.
Adverse events for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details may be found here: http://www.tevapharm.com/en-US/Pages/Contact-Us.aspx